Resumo

GARCIA LUQUE, A.; PUERRO VICENTE, M.; SANCHEZ LOPEZ, P.  e  CABANES MARISCAL, M.A.. Positive assessment of drugs: 2^nd quarter 2012. Sanid. Mil. [online]. 2012, vol.68, n.3, pp.177-181. ISSN 1887-8571.  https://dx.doi.org/10.4321/S1887-85712012000300009.

The drugs assessed by the Spanish Agency for Medicines and Health Products made public in the second quarter of 2012, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palavras-chave : Axitinib; Inlyta; Aclidinio Bromuro; Eklira; Bretaris Genuair; Glicopirronio; Enurev; Seebri; Tovanor; Breezhaler; Catridecacog; Novothirteen; Ceftarolina fosamil; Zinforo; Cobre (⁶⁴Cu) Cloruro de; Cuprymina; Dapaglifocina; Forxiga; Ferumoxytol; Rienso; Ivacaftor; Yervoy; Linagliptina/metformina hidrocloruro; Jentadueto; Perampanel; Fycompa; Ruxolitinib; Jakavi; Teduglutida; Revestive.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )